Director Senior Corporate Counsel France positions focus on delivering results in their domain. This page aggregates open Director Senior Corporate Counsel France roles and what employers typically expect.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: We are seeking an experienced, commercially focused Director, Senior Corporate Counsel to serve as the primary legal advisor to the French affiliate during the launch and commercialization of its first oncology product. Initially reporting to the VP, Legal, Europe, with a strong dotted reporting line to the General Manager, France, this role will provide practical, risk-based legal advice across commercial operations, market access, competition law, healthcare compliance, contracting, litigation and external stakeholder engagement. Once recruited, the incumbent will report to the Associate General Counsel, Europe. The successful candidate will be a proactive business partner who balances legal risk with commercial objectives in a fast-paced launch environment. This is an opportunity to shape the legal strategy for one of the Company’s key European markets while partnering closely with French and European leadership to help build a high-performing commercial organization. This role complements the Associate Director, Corporate Counsel Distributor Markets, Europe position. Together, they create a clean split of responsibilities: France Counsel: In-market legal support for the French affiliate, including the GM, market access, competition law, litigation, local legal issues, and business partnerships. Distributor Markets Counsel: Cross-border commercial contracting and governance for all European distributor markets outside the company's direct affiliate footprint, with responsibility for negotiating and managing distribution relationships. Key Responsibilities Strategic Business Partner Serve as the primary legal advisor to the General Manager, France and local Leadership Team. Provide practical, solution-oriented legal advice to support commercial decision-making and business strategy. Participate as a trusted member of the French leadership team, proactively identifying legal risks and opportunities. Support the successful launch and ongoing commercialization of the Company's oncology portfolio in France. Commercial, Contracting & Business Partner Support & In-Market Legal Advice Advise on commercial operations in France, including Sales, Marketing, Medical Affairs, Market Access, Government Affairs, Regulatory Affairs and Finance. Provide legal support for promotional activities, field-based engagements, digital initiatives, early access and patient support programs. Draft, review and negotiate commercial agreements with consultants, vendors, service providers and strategic partners. Support third-party due diligence, collaboration governance and ongoing business partner relationship management. Market Access & Pricing Lead legal support for pricing, reimbursement, tenders, healthcare contracting and market access initiatives. Draft and negotiate rebate agreements, market access agreements and value-based arrangements with statutory and private healthcare stakeholders. Partner with Market Access and Government Affairs to assess the legal impact of evolving reimbursement policies. Competition & Healthcare Law Advise on French and European competition law issues affecting pharmaceutical commercialization, including pricing, distribution, information exchanges, coll…